Last reviewed · How we verify

NCT04544072

Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards

Status unknown Last updated 10 September 2020
What this trial tests

trial in SARS-CoV Infection in 400 participants. Status unknown.

Timeline
1 May 2020
Primary endpoint
1 December 2020
1 March 2021

Quick facts

Lead sponsorUniversitair Ziekenhuis Brussel
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date1 May 2020
Primary completion1 December 2020
Estimated completion1 March 2021
Sites1 location across Belgium

Conditions studied

Sponsor

Universitair Ziekenhuis Brussel — full company profile →

Who can join

18 and older, any sex, with SARS-CoV Infection or Antimicrobial Stewardship. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective observational study, a quantitative and qualitative analysis of antibiotic prescriptions for presumed respiratory tract (super)infection in patients hospitalized on COVID-19 wards will be made. Drivers of antibiotic prescription for presumed respiratory tract infection in patients suspected of being infected with COVID-19 or with definite COVID-19 infections will be identified.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study.
    Van Laethem J, Wuyts S, Van Laere S, Dirkx S, et al · · 2021 · cited 6× · PMID 34529255 · DOI 10.1007/s40121-021-00535-2

Verify or expand the search:

Other recruiting trials for SARS-CoV Infection

Currently open trials in the same condition.

Other Universitair Ziekenhuis Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04544072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing